US · Healthcare · Health Information Services
EPS came in at 0.45 against a street estimate of 0.37 — a beat of 21.6%.
Analysts rate BrightSpring Health Services, Inc. Common Stock a strong buy (11 buy, 1 hold, 0 sell out of 12) with an average price target of $78.94.
CONFIDENT BrightSpring beat Q2 expectations with $3.9B revenue (+23% YoY) and $206M adjusted EBITDA (+44% YoY). Pharmacy Solutions grew 22%, Provider Services 30%. Guidance raised; leverage improved to 2.15x. Q2 2026 No geographic breakdown provided in call. Analysts pressed on generic ramps (Revlimid, 2027 pipeline), pharmacy margin seasonality vs. structural, and IRA/tariff headwinds. Management emphasized operational leverage, multiple growth levers (fee-for-service, LDDs, volumes), and control of what management can control despite policy headwinds. No major red flags; execution confidence high. 2026-07-31…
Full summary in the app.
| Fund | Stake |
|---|---|
| Kohlberg Kravis Roberts & Co LP | 21.14% |
| FMR Inc | 10.60% |
| BlackRock Inc | 9.91% |
| Amvescap Plc. | 5.80% |
| T. Rowe Price Associates, Inc. | 5.39% |
| Vanguard Portfolio Management, LLC | 4.06% |
| T. Rowe Price Investment Management,Inc. | 3.86% |
| Vanguard Capital Management, LLC | 3.18% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 BRIGHTSPRING HEALTH SERVICES, INC. - Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Total revenues: $3.87 billion (Q2 2026), up 23% vs Q2 2025 ($3.15 billi | 2026-07-31 |
| Results announced · Q3 2026 BRIGHTSPRING HEALTH SERVICES, INC. – Q2 2026 RESULTS SUMMARY HEADLINE NUMBERS • Net revenue Q2 2026: $3,873 million, up 23.0% vs. $3,148 million Q2 | 2026-07-31 |
| Board / officer change · Q2 2026 BRIGHTSPRING HEALTH SERVICES, INC. – 8-K SUMMARY HEADLINE NUMBERS • Board Size: Expanded from 7 to 8 directors on June 11, 2026 • New Director: Dr. | 2026-06-12 |
| Material agreement · Q2 2026 BRIGHTSPRING HEALTH SERVICES, INC. - 8-K SUMMARY HEADLINE NUMBERS • Stock offering price: $58.75 per share • Shares sold by existing shareholders: 1 | 2026-06-05 |
| Shareholder vote results · Q2 2026 BRIGHTSPRING HEALTH SERVICES, INC. - 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting held May 21, 2026 with 186,457,085.30 shares present or represent | 2026-05-21 |
| Quarterly report · Q1 2026 BRIGHTSPRING HEALTH SERVICES, INC. – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Total revenues: $3,613.7 million (Q1 2026) vs. $2,878.1 million (Q1 202 | 2026-05-01 |
| Proxy statement · Q2 2026 BRIGHTSPRING HEALTH SERVICES, INC. – PROXY SUMMARY FOR RETAIL INVESTORS --- WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Elect three Class II dire | 2026-04-10 |
| Annual report FY2025 BRIGHTSPRING HEALTH SERVICES, INC. – 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Company: BrightSpring Health Services, Inc. (Nasdaq: BTSG, | 2026-02-27 |
Readable in the app.
| Announcement | Date |
|---|---|
| Q2 2026 results announced; full year 2026 revenue and EBITDA guidance increased BrightSpring Health Services reported strong second quarter 2026 results and raised full-year guidance. Key highlights: Revenue grew 23% to $3.87 billion (vs. $3.15 billion last year), Gross | 2026-07-31 |
| Q1 2026 results reported; full year 2026 revenue and EBITDA guidance increased BrightSpring Health Services reported strong Q1 2026 results and raised full-year guidance. Revenue jumped 25.6% to $3.6 billion, while gross profit surged 42.5% to $482 million and net inco | 2026-05-01 |
| Q4 2025 results and full year 2026 revenue and EBITDA guidance initiated BrightSpring Health Services reported strong 2025 financial results and provided 2026 guidance. Revenue grew 28.2% year-over-year to $12.9 billion, driven by its two business segments: Pharm | 2026-02-27 |
| Q3 2025 results reported; full year 2025 revenue guidance increased BrightSpring Health Services reported strong third quarter 2025 results with significant growth across key metrics. Revenues surged 28.2% to $3.334 billion, while Adjusted EBITDA jumped 37.2 | 2025-10-28 |
| Increased full year 2025 revenue and adjusted EBITDA guidance BrightSpring Health Services reported strong third quarter 2025 preliminary results and raised its full-year guidance. Key highlights: Q3 revenues reached $3.334 billion, up 28.2% year-over- | 2025-10-20 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for BrightSpring Health Services, Inc. Common Stock — free to start.
Google PlayApp StoreData updated 2026-09-18.